Skip to main content
. 2022 Apr 2;11:100249. doi: 10.1016/j.lana.2022.100249

Figure 2.

Fig 2

Adjusted* predicted probability of use of obesogenic medications among US adults who had overweight or obesity and took at least one prescription medication by (a) composite SES, (b) education, (c) household income, and (d) type of health insurance, NHANES 2009-2018.

*The model adjusted for age, sex, race/ethnicity, number of prescription medications, diabetes, depression, hypertension, cardiovascular disease, and arthritis.